Total Payments
$11,030
2024 Payments
$1,605
Companies
56
Transactions
703
Medicare Patients
4,439
Medicare Billing
$452,865
Payment Breakdown by Category
Food & Beverage$11,001 (99.7%)
Education$28.72 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,001 | 697 | 99.7% |
| Education | $28.72 | 6 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,569 | 98 | $0 (2024) |
| Merck Sharp & Dohme LLC | $1,189 | 77 | $0 (2024) |
| Melinta Therapeutics, LLC | $1,006 | 56 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $807.60 | 55 | $0 (2024) |
| Paratek Pharmaceuticals, Inc. | $650.82 | 43 | $0 (2024) |
| Amgen Inc. | $609.46 | 36 | $0 (2023) |
| ABBVIE INC. | $592.78 | 45 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $566.09 | 37 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $490.86 | 34 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $465.82 | 28 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,605 | 90 | Novo Nordisk Inc ($213.12) |
| 2023 | $1,926 | 110 | Novo Nordisk Inc ($243.94) |
| 2022 | $1,629 | 102 | Novo Nordisk Inc ($231.64) |
| 2021 | $789.84 | 48 | Paratek Pharmaceuticals, Inc. ($237.93) |
| 2020 | $733.71 | 48 | Paratek Pharmaceuticals, Inc. ($150.22) |
| 2019 | $1,129 | 76 | Novo Nordisk Inc ($207.04) |
| 2018 | $1,376 | 94 | Novo Nordisk Inc ($216.76) |
| 2017 | $1,842 | 135 | Boehringer Ingelheim Pharmaceuticals, Inc. ($267.66) |
All Payment Transactions
703 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $9.94 | General |
| Category: Obesity | ||||||
| 12/12/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZERBAXA | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 12/10/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: RESPIRATORY | ||||||
| 12/05/2024 | Melinta Therapeutics, LLC | Kimyrsa (Drug), Orbactiv, Rezzayo | Food and Beverage | In-kind items and services | $23.11 | General |
| Category: ANTIBIOTICS | ||||||
| 12/05/2024 | Melinta Therapeutics, LLC | Kimyrsa (Drug), Orbactiv, Rezzayo | Food and Beverage | In-kind items and services | $3.20 | General |
| Category: ANTIBIOTICS | ||||||
| 12/04/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: Oncology | ||||||
| 11/26/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: Diabetes | ||||||
| 11/21/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $23.91 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: Cardio-renal | ||||||
| 11/14/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZERBAXA | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: NEUROSCIENCE | ||||||
| 11/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: RESPIRATORY | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/06/2024 | Melinta Therapeutics, LLC | Rezzayo (Drug), Kimyrsa, Orbactiv | Food and Beverage | In-kind items and services | $20.89 | General |
| Category: ANTIFUNGALS | ||||||
| 11/03/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: Diabetes | ||||||
| 10/31/2024 | ABBVIE INC. | DALVANCE (Drug), AVYCAZ, TEFLARO | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/30/2024 | Organogenesis Inc. | PURAPLY AM (Device) | Food and Beverage | In-kind items and services | $31.07 | General |
| Category: WOUND CARE | ||||||
| 10/25/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $11.62 | General |
| Category: Diabetes | ||||||
| 10/24/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: ANTIBIOTIC | ||||||
| 10/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: Cardio-renal | ||||||
| 10/14/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: RESPIRATORY | ||||||
| 10/11/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: DERMATOLOGY | ||||||
| 10/10/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZERBAXA | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/08/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.59 | General |
| Category: Obesity | ||||||
| 10/08/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.94 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 762 | 1,811 | $218,435 | $100,863 |
| 2022 | 13 | 843 | 1,876 | $216,721 | $113,582 |
| 2021 | 23 | 1,215 | 2,796 | $246,443 | $122,852 |
| 2020 | 24 | 1,619 | 3,259 | $285,587 | $115,568 |
Total Patients
4,439
Total Services
9,742
Medicare Billing
$452,865
Procedure Codes
77
All Medicare Procedures & Services
77 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 270 | 909 | $145,255 | $70,497 | 48.5% |
| 11042 | Removal of skin and tissue, 20.0 sq cm or less | Facility | 2023 | 30 | 225 | $36,225 | $9,659 | 26.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 100 | 100 | $7,820 | $7,133 | 91.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 41 | 87 | $9,850 | $4,742 | 48.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 102 | 102 | $3,570 | $2,907 | 81.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 20 | 20 | $3,000 | $2,412 | 80.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 13 | 16 | $2,320 | $1,067 | 46.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 66 | 102 | $3,570 | $938.80 | 26.3% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 13 | 16 | $640.00 | $553.92 | 86.6% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2023 | 43 | 111 | $3,330 | $489.35 | 14.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 12 | 12 | $420.00 | $342.00 | 81.4% |
| 81003 | Automated urinalysis test | Office | 2023 | 32 | 43 | $1,075 | $94.60 | 8.8% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 20 | 68 | $1,360 | $27.44 | 2.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 300 | 989 | $143,405 | $76,480 | 53.3% |
| 11042 | Removal of skin and tissue, 20.0 sq cm or less | Facility | 2022 | 31 | 185 | $29,785 | $8,092 | 27.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 115 | 115 | $8,050 | $7,882 | 97.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 38 | 81 | $8,100 | $4,953 | 61.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 30 | 30 | $4,500 | $3,722 | 82.7% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 13 | 13 | $5,200 | $3,634 | 69.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 118 | 118 | $4,130 | $3,228 | 78.2% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 18 | 18 | $2,574 | $2,370 | 92.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 12 | 13 | $1,885 | $986.49 | 52.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 34 | 35 | $1,192 | $955.08 | 80.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 50 | 94 | $3,260 | $797.68 | 24.5% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2022 | 30 | 70 | $2,100 | $354.53 | 16.9% |
About Dr. David Chalk, MD
Dr. David Chalk, MD is a Family Medicine healthcare provider based in Anniston, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/23/2005. The National Provider Identifier (NPI) number assigned to this provider is 1134106800.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Chalk, MD has received a total of $11,030 in payments from pharmaceutical and medical device companies, with $1,605 received in 2024. These payments were reported across 703 transactions from 56 companies. The most common payment nature is "Food and Beverage" ($11,001).
As a Medicare-enrolled provider, Chalk has provided services to 4,439 Medicare beneficiaries, totaling 9,742 services with total Medicare billing of $452,865. Data is available for 4 years (2020–2023), covering 77 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Anniston, AL
- Active Since 12/23/2005
- Last Updated 10/17/2016
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1134106800
Products in Payments
- NUZYRA (Drug) $650.82
- Ozempic (Drug) $580.37
- DIFICID (Drug) $519.07
- XARELTO (Drug) $474.28
- Kerendia (Drug) $465.82
- Kimyrsa (Drug) $441.33
- ZERBAXA (Drug) $419.00
- FARXIGA (Drug) $407.53
- ELIQUIS (Drug) $344.31
- Orbactiv (Drug) $322.48
- JARDIANCE (Drug) $320.24
- TRELEGY ELLIPTA (Drug) $309.52
- VRAYLAR (Drug) $271.87
- TRADJENTA (Drug) $264.81
- Rybelsus (Drug) $232.86
- DALVANCE (Drug) $222.68
- Victoza (Drug) $217.78
- VIBATIV (Drug) $193.86
- MOUNJARO (Drug) $190.77
- Otezla (Drug) $189.39
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Anniston
Michael Proctor, Md,Faafp, MD,FAAFP
Family Medicine — Payments: $29,719
Family Medicine $29,719
Dr. Ty Stansell, Md, MD
Family Medicine — Payments: $7,930
Family Medicine $7,930
Dr. Nelson Cook, M.d, M.D
Family Medicine — Payments: $6,237
Family Medicine $6,237
Robert Cater, Md,Aafp, MD,AAFP
Family Medicine — Payments: $2,123
Family Medicine $2,123
Mary Rutherford, Md, MD
Family Medicine — Payments: $1,981
Family Medicine $1,981
Michael Sesay, Md, MD
Family Medicine — Payments: $820.59
Family Medicine $820.59